| 注册
首页|期刊导航|广州医药|干细胞疗法及神经调控技术在脊髓损伤中的研究进展

干细胞疗法及神经调控技术在脊髓损伤中的研究进展

张彩玲 兰月 马瑗锾

广州医药2024,Vol.55Issue(7):689-704,16.
广州医药2024,Vol.55Issue(7):689-704,16.DOI:10.3969/j.issn.1000-8535.2024.07.001

干细胞疗法及神经调控技术在脊髓损伤中的研究进展

Research progress on application of stem cell and neuromodulation technology in spinal cord injury

张彩玲 1兰月 2马瑗锾3

作者信息

  • 1. 华南理工大学附属第二医院(广州市第一人民医院)临床医学研究所(广东广州 510180)||华南理工大学附属第二医院(广州市第一人民医院)康复医学科(广东广州 510180)
  • 2. 华南理工大学附属第二医院(广州市第一人民医院)康复医学科(广东广州 510180)
  • 3. 华南理工大学附属第二医院(广州市第一人民医院)临床医学研究所(广东广州 510180)
  • 折叠

摘要

Abstract

Spinal cord injury is a highly disabling disease of the central nervous system without effective treatment to date.With the rise of stem cell and tissue engineering,and the breakthrough of neuromodulation technology,it brings new hope to the treatment of spinal cord injury.At present,a number of clinical studies on stem cell-related treatment projects for spinal cord injury have been registered worldwide,which has become a research hotspot.Neuromodulation technology has been playing an important role in the clinical rehabilitation of spinal cord injury.Especially,breakthroughs have been made in the treatment of spinal cord injury by targeted neuromodulation technology in recent years,which is encouraging.Some studies have attempted to combine stem cell therapy and neuromodulation technology to treat spinal cord injuries in an attempt to achieve better effect.This review summarizes the research progress of stem cell therapy and neuromodulation technology in the treatment of spinal cord injury,with the aim of discussing their effect,repair mechanisms,application prospect and various problems to face,and providing further reference for the basic research and clinical transformation of spinal cord injury.

关键词

脊髓损伤/干细胞/组织工程/类器官/神经调控技术/再生医学

Key words

spinal cord injury/stem cells/tissue engineering/organoids/neuromodulation technology/regenerative medicine

引用本文复制引用

张彩玲,兰月,马瑗锾..干细胞疗法及神经调控技术在脊髓损伤中的研究进展[J].广州医药,2024,55(7):689-704,16.

基金项目

广东省自然科学基金青年提升项目(2023A1515030254) (2023A1515030254)

广州市科技计划项目(202206010197) (202206010197)

广州医药

1000-8535

访问量0
|
下载量0
段落导航相关论文